Tecentriq 1,200 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FKELH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,006
Award facts
- Contract value 100% obligated
- $13,005.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 2, 2025, valued at $13,005.98 for the supply of Tecentriq 1,200 mg/20 mL vials. This firm fixed-price delivery order is set to be completed by September 23, 2025, with performance occurring at the company's Park Ridge facility. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on equal footing with other qualified vendors. Tecentriq is a prescription oncology medication used in cancer treatment, reflecting the company's established role in supplying specialized pharmaceutical products to federal healthcare systems.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The parent contract enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide. As a cornerstone supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has consistently leveraged its woman-owned small business status to secure contracts for prescription medications, biologics, and medical consumables distributed directly to Department of Defense healthcare sites nationwide.
Quick answers
Who was awarded contract SPE2DB25FKELH?
SPE2DB25FKELH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FKELH worth?
The government has obligated $13,006 on SPE2DB25FKELH.
Is contract SPE2DB25FKELH an order under another contract?
Yes. SPE2DB25FKELH is a delivery order under SPE2DB24D9223, an indefinite delivery contract.
Was contract SPE2DB25FKELH competed?
The extent of competition for SPE2DB25FKELH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award